Omnipotent Bio Ltd

Registered number: 14940118

	30 June 2025	30 June 2024
	£	£
Fixed assets	142,956	104,327

Current assets	3,225,624	3,475,866
Prepayments and accrued income	21,478	12,834
Creditors: Amounts Falling Due Within One Year	(5,520,823 )	(4,193,222 )

NET CURRENT LIABILITIES	(2,273,721 )	(704,522 )

TOTAL ASSETS LESS CURRENT LIABILITIES	(2,130,765 )	(600,195 )

Accruals and deferred income	(33,242 )	(3,500 )

NET LIABILITIES	(2,164,007 )	(603,695 )

CAPITAL AND RESERVES	(2,164,007 )	(603,695 )

Notes

1. General Information

Omnipotent Bio Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14940118 . The registered office is London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH.

2. Average Number of Employees

Average number of employees, including directors, during the year was as follows: 9 (2024: 4)

3. Other Commitments

The total of future minimum lease payments under non-cancellable operating leases are as following:

	30 June 2025	30 June 2024
	£	£
Not later than one year	15,385	9,016

	15,385	9,016

4. Going concern disclosure

The company's financial statements have been prepared on a going concern basis on the grounds that current and future sources of funding or support will be more than adequate for the company's needs. In assessing going concern, the directors have a reasonable expectation that the company will continue as a going concern and is able to meet all of its obligations as they fall due for a minimum of 12 months from the date of approval of these financial statements.

For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

On behalf of the board

H M Barbosa Triana

Director

29 April 2026